Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
about
A new insight into hepatitis C vaccine developmentMechanisms of viral entry: sneaking in the front doorT-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria MarburgvirusPhospholipid scramblase 1 mediates hepatitis C virus entry into host cellsReplication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122Identification of rodent homologs of hepatitis C virus and pegivirusesHepatitis C virus hijacks host lipid metabolismHepatitis C virus and neurological damageApplications of Replicating-Competent Reporter-Expressing Viruses in Diagnostic and Molecular VirologyRecent advances in understanding hepatitis CEntry inhibitors: New advances in HCV treatmentHost restriction factors for hepatitis C virusStatus of hepatitis C virus vaccination: Recent updateRoles of lipoprotein receptors in the entry of hepatitis C virusInterferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV)Tight Junctions Go Viral!Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virusAnimal models for the study of HCVGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignCuring a viral infection by targeting the host: the example of cyclophilin inhibitorsNew hepatitis C virus drug discovery strategies and model systemsHepatitis C virus molecular evolution: transmission, disease progression and antiviral therapyImpact of lipids and lipoproteins on hepatitis C virus infection and virus neutralizationMurine models of hepatitis C: what can we look forward to?Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseasesModeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infectionsMouse models of hepatitis B virus infection comprising host-virus immunologic interactionsT cell responses in hepatitis C virus infection: historical overview and goals for future researchViral quasispecies evolutionThe actin cytoskeleton as a barrier to virus infection of polarized epithelial cellsDirect acting antivirals for the treatment of chronic viral hepatitisThe hepatitis C virus glycan shield and evasion of the humoral immune responseSelection and refinement: the malaria parasite's infection and exploitation of host hepatocytesNeutralizing antibody response to hepatitis C virusTamiflu-resistant but HA-mediated cell-to-cell transmission through apical membranes of cell-associated influenza virusesTick-borne encephalitis virus replication, intracellular trafficking, and pathogenicity in human intestinal Caco-2 cell monolayersMolecular determinants and dynamics of hepatitis C virus secretionMouse Systems to Model Hepatitis C Virus Treatment and Associated ResistancePolarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma CellsHepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
P2860
Q21296858-93EA91C0-41AC-4F2E-9F02-4BEF2F1AD6C6Q22252690-254899CE-F8B4-4B7A-8C0C-405A76ECC452Q24301153-E5C27947-31F5-49D7-A191-C8EBCF6C87D9Q24318390-43A7B3B3-0379-48BB-B077-A784BF864330Q24611792-8923D9F2-1982-45F0-B7E1-721C72C3C11BQ24634479-8FA3E591-8491-4ACB-8B17-FCD1E97DC982Q24652319-C5AF9847-B2E2-4425-9A98-3E1D97F1FEE3Q26748575-F78192F8-2A10-4531-A847-93C0133C29F5Q26750838-D801FC33-1744-4106-8FB3-75B6B4D09355Q26766136-D31F73AF-7E35-46F8-B716-F6D6A1C29123Q26770817-58C85671-7FDF-427B-926F-4BE427103275Q26773258-F9366405-C57B-4283-A11F-BE6814898244Q26774612-3B1D6AE5-3941-4D8B-8467-19347D87BA4AQ26777338-8C3191EB-349E-448C-8311-B5FE370F857CQ26778005-764A7E4C-9E37-42FB-AB45-19F5C8D85B38Q26781335-A18BFBCC-3C0E-43AD-ACA7-F8BA091D8D74Q26783378-54469D95-D7D9-4821-B070-0F592A21A50EQ26797836-624A2A78-7C7A-482B-8C44-ADF4DF164048Q26801759-705EB8E1-4E0B-4E25-ABDB-F31326E3DC5EQ26828727-14531FC7-328E-4547-AC26-73F95D541F76Q26851159-260BCD40-3EDF-4038-9711-82EADAC09814Q26853500-365E984D-1A40-4D19-9CCE-291FE8F046C7Q26864485-FEB445D2-2661-463A-B31E-1956107EDCF5Q26991875-F2FE337F-13E7-4B75-B491-52ABB56890D4Q26992256-057FE819-5647-47D2-B387-9A65E4898398Q27002381-B5382359-184B-44FF-9BF9-796A46F7E284Q27002598-FA549778-DF0E-4664-920F-6205B2400282Q27003510-611971A5-E26E-4ABE-B6D2-2DF25422CDF1Q27013917-005CB3CF-5192-4665-B2B3-2BFB0A93B024Q27015995-1094EE0A-DCFF-429E-8E28-8C3C4C3A0858Q27022216-A0D81023-FAFD-468D-8D58-803E83880B0CQ27023390-FBA96E64-B2A0-441B-AB43-30525C2674A2Q27025899-AD0CB03D-39C1-4E5D-A064-51B734D314AFQ27027484-484E1B51-B4E0-40A4-89B0-013AF36C371EQ27311553-5B9BF9FE-7526-468D-8589-76E4C0F55D3EQ27333771-8928661F-9771-461F-B6F3-4C9A46BAD8A3Q27347838-6312C2E9-DFDA-48D2-A2A7-4BC1A3AAF276Q27469038-B51204C8-B4D6-46FB-9DDD-A9CFF41C0DC9Q27488433-3DD80D0D-1229-4A1F-A77D-CE0B3392EE70Q27488844-72E7906C-817F-4A54-BA1A-C5FE9591B219
P2860
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
@ast
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
@en
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
@nl
type
label
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
@ast
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
@en
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
@nl
prefLabel
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
@ast
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
@en
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
@nl
P2093
P2860
P3181
P356
P1433
P1476
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
@en
P2093
Alexander Ploss
Charles M Rice
Maryline Panis
Matthew J Evans
Valeriya A Gaysinskaya
Ype P de Jong
P2860
P2888
P3181
P356
10.1038/NATURE07684
P407
P577
2009-02-12T00:00:00Z
P5875
P6179
1044772574